Oxolinic Acid, a distinguished second-generation quinolone antibiotic, holds a pivotal position in veterinary pharmacology, particularly within the flourishing domain of aquaculture. First introduced in Japan in the 1970s, this compound has consistently demonstrated its profound efficacy in suppressing a broad spectrum of bacterial infections, rendering it an indispensable asset for safeguarding the health and vitality of aquatic populations.

This potent active pharmaceutical ingredient (API) typically appears as a fine white to yellow-white columnar crystal or crystalline powder. It is entirely odorless and tasteless at ambient temperatures, making it a highly adaptable raw material for various formulations. The remarkable effectiveness of Oxolinic Acid is attributed to its precise mode of action: it operates by selectively inhibiting the enzyme DNA gyrase within bacterial cells. Since DNA gyrase is critical for bacterial DNA replication, transcription, and repair, its inhibition effectively halts bacterial growth and multiplication, thereby leading to the resolution of infectious processes.

Oxolinic Acid exhibits a robust, broad-spectrum antibacterial profile, showing significant activity against numerous gram-negative bacteria and a subset of gram-positive strains. A key therapeutic advantage of Oxolinic Acid is its distinct mechanism of action, which minimizes the likelihood of cross-resistance with other commonly used antibiotics, making it a valuable option in challenging treatment scenarios. It is noteworthy that Oxolinic Acid does not possess antibacterial efficacy against fungi or mycobacterium tuberculosis, which underlines its targeted application focus. Its high potency allows for low effective dosages, contributing to both cost-effectiveness and reduced environmental impact.

The paramount application for Oxolinic Acid is in the comprehensive treatment of bacterial diseases impacting fish, shrimp, and other commercially important aquatic animals. Within the aquaculture industry, it is widely regarded as one of the most reliable and effective pharmaceutical interventions for aquatic animal ailments. Studies and practical applications have consistently shown its substantial antibacterial power against prevalent fish pathogens such as Vibrio anguillarum and Aeromonas hydrophila. Furthermore, Oxolinic Acid provides significant therapeutic benefits for a range of specific conditions, including furunculosis, vibriosis, sarcoidosis, red fin disease, red spot disease, canker disease, and enteritis. Beyond direct aquatic treatment, its versatile properties also lend themselves to agricultural use, specifically in seed treatment to prevent bacterial blight, thereby fostering healthier plant development.

As a reputable manufacturer and supplier of high-quality pharmaceutical raw materials, NINGBO INNO PHARMCHEM CO.,LTD. is committed to delivering Oxolinic Acid that adheres to stringent GMP guidelines and boasts a purity level consistently exceeding 99%. Our dedication to excellence spans every stage, from the scrupulous selection of raw materials to advanced synthesis processes, comprehensive quality control, and responsive customer support. We assure our clients that our Oxolinic Acid is of the highest pharmaceutical grade, making it ideal for the most demanding API applications.

For enterprises seeking to buy Oxolinic Acid, NINGBO INNO PHARMCHEM CO.,LTD. provides competitive price structures designed to maximize value without compromising on product integrity. We recognize the critical importance of a streamlined and secure purchase process and efficient delivery for our global clientele. Leveraging a sophisticated logistical network, we facilitate reliable transportation via air, sea, and land, guaranteeing the timely and safe arrival of orders. Whether your requirement is for bulk quantities or specialized consignments, our expert team is poised to cater to your needs with unmatched professionalism and efficiency. We maintain a substantial inventory to ensure immediate dispatch and minimize lead times.